Novo Nordisk's Wegovy Exceeds 130,000 Weekly Prescriptions in North America
Thursday, 2 May 2024, 07:53
Novo Nordisk's Wegovy Weight-Loss Drug Achieves Milestone
Novo Nordisk has seen significant success with its injectable weight-loss drug, Wegovy, which now boasts over 130,000 weekly prescriptions in North America alone. The company's proactive response to escalating demand by ramping up supplies has bolstered its financial performance.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.